Richard A. Rettig — Publications

Special Treatment — The Story of Medicare's ESRD Entitlement

2011
Chronic Kidney Disease — A Quiet Revolution in Nephrology: Six Case Studies

2010
A "Quiet Revolution" in Nephrology: Challenges and Opportunities for Advancing the Treatment of Chronic Kidney Disease

2010
Chronic Kidney Disease in the United States: A Public Policy Imperative

2008
Design of the Qatar National Research Fund: An Overview of the Study Approach and Key Recommendations

2008
False Hope: Bone Marrow Transplantation for Breast Cancer

2007
Examining Possible Causes of Gulf War Illness: RAND Policy Investigations and Reviews of the Scientific Literature

2005
Reorganizing the National Institutes of Health: A Review of an Important National Research Council-Institute of Medicine Report to Revitalize the NIH

2004
Why Is Revitalizing Clinical Research So Important, Yet So Difficult?

2004
The Acquisition of Drugs and Biologics for Chemical and Biological Warfare Defense: Department of Defense Interactions with the Food and Drug Administration

2003
The Food and Drug Administration Confronts Homeland and National Security: Report on a Workshop of the RAND Center for Domestic and International Health Security

2003
If Daily Dialysis Is the Answer, What Is the Question?

2001
Are Patients a Scarce Resource for Academic Clinical Research?

2000
The Industrialization of Clinical Research

2000
Introduction: [The] Economics of Nephrology]

2000
The Political Economy of Nephrology

2000
Waiving Informed Consent: Military Use of Non-FDA-Approved Drugs in Combat

2000
Medicare's End-Stage Renal Disease Program: Current Status and Future Prospects

1999
Military Use of Drugs Not Yet Approved by the FDA for CW/BW Defense: Lessons from the Gulf War

1999
Assessing Health and Quality of Life Outcomes in Dialysis: A Report on an Institute of Medicine Workshop

1997
Health Care in Transition: Technology Assessment in the Private Sector

1997
The Machine Age in Medicine

1997
Measuring and Improving the Health Status of End Stage Renal Disease Patients

1997
The social contract and the treatment of permanent kidney failure

1996
The Cost Effects of Improved Kidney Transplantation

1984
The Federal Government and Social Planning for End-Stage Renal Disease: Past, Present, and Future

1983
Testimony before Investigations and Oversight Committee, Committee on Science and Technology, U.S. House of Representatives, April 27, 1983

1983
The breast cancer networks : organizing to improve management of a disease

1981
Implementing the End-Stage Renal Disease Program of Medicare

1980
Mechanisms for the implementation of civil rights guarantees by educational institutions

1980
The Development of Medical Technology: A Policy Perspective

1979
The Federal Government and Medical Technology: Crossing Policy and Management Thresholds

1979
Reflections on ''The Cancer Crusade''

1978
The Role of Demonstrations in Federal R&D Policy

1978
End-Stage Renal Disease and the ''Cost'' of Medical Technology

1977
Analysis of Federally Funded Demonstration Projects: Supporting Case Studies

1976
Health care technology: lessons learned from the end-stage renal disease experience

1976
Policy Analysis for Federal Biomedical Research

1976
The use of consortia for the management of research and development: The Clemson University ETIP flammability project

1976
Valuing Lives: The Policy Debate on Patient Care Financing for Victims of End-Stage Renal Disease

1976
Implementation of the End-Stage Renal Disease Program: A Mixed Pattern of Subsidizing and Regulating the Delivery of Medical Services

1975

Federally Funded Research Divisions

Social and Economic Policy Divisions

International

Richard A. Rettig — Publications

Special Treatment — The Story of Medicare's ESRD Entitlement

Chronic Kidney Disease — A Quiet Revolution in Nephrology: Six Case Studies

A "Quiet Revolution" in Nephrology: Challenges and Opportunities for Advancing the Treatment of Chronic Kidney Disease

Chronic Kidney Disease in the United States: A Public Policy Imperative

Design of the Qatar National Research Fund: An Overview of the Study Approach and Key Recommendations

False Hope: Bone Marrow Transplantation for Breast Cancer

Examining Possible Causes of Gulf War Illness: RAND Policy Investigations and Reviews of the Scientific Literature

Reorganizing the National Institutes of Health: A Review of an Important National Research Council-Institute of Medicine Report to Revitalize the NIH

Why Is Revitalizing Clinical Research So Important, Yet So Difficult?

The Acquisition of Drugs and Biologics for Chemical and Biological Warfare Defense: Department of Defense Interactions with the Food and Drug Administration

The Food and Drug Administration Confronts Homeland and National Security: Report on a Workshop of the RAND Center for Domestic and International Health Security

If Daily Dialysis Is the Answer, What Is the Question?

Are Patients a Scarce Resource for Academic Clinical Research?

The Industrialization of Clinical Research

Introduction: [The] Economics of Nephrology]

The Political Economy of Nephrology

Waiving Informed Consent: Military Use of Non-FDA-Approved Drugs in Combat

Medicare's End-Stage Renal Disease Program: Current Status and Future Prospects

Military Use of Drugs Not Yet Approved by the FDA for CW/BW Defense: Lessons from the Gulf War

Assessing Health and Quality of Life Outcomes in Dialysis: A Report on an Institute of Medicine Workshop

Health Care in Transition: Technology Assessment in the Private Sector

The Machine Age in Medicine

Measuring and Improving the Health Status of End Stage Renal Disease Patients

The social contract and the treatment of permanent kidney failure

The Cost Effects of Improved Kidney Transplantation

The Federal Government and Social Planning for End-Stage Renal Disease: Past, Present, and Future

Testimony before Investigations and Oversight Committee, Committee on Science and Technology, U.S. House of Representatives, April 27, 1983

The breast cancer networks : organizing to improve management of a disease

Implementing the End-Stage Renal Disease Program of Medicare

Mechanisms for the implementation of civil rights guarantees by educational institutions

The Development of Medical Technology: A Policy Perspective

The Federal Government and Medical Technology: Crossing Policy and Management Thresholds

Reflections on ''The Cancer Crusade''

The Role of Demonstrations in Federal R&D Policy

End-Stage Renal Disease and the ''Cost'' of Medical Technology

Analysis of Federally Funded Demonstration Projects: Supporting Case Studies

Health care technology: lessons learned from the end-stage renal disease experience

Policy Analysis for Federal Biomedical Research

The use of consortia for the management of research and development: The Clemson University ETIP flammability project

Valuing Lives: The Policy Debate on Patient Care Financing for Victims of End-Stage Renal Disease

Implementation of the End-Stage Renal Disease Program: A Mixed Pattern of Subsidizing and Regulating the Delivery of Medical Services